Strategy

Virtual development speeds up Verona Pharma

Read more

Why invest in the US, when Europe beckons?

Read more

Can R&D strategy meet societal needs?

Read more

A turning point for the biopharma industry?

Read more

Innovation points to a bright future

Read more

Europe's pharma uses deals to rationalise

Read more

Forbion looks for emerging science

Read more

How Britain champions medical innovation

Read more

How outcomes measures can improve healthcare

Read more

Commentary: Big deals for Big Pharma

Read more